Increased Levels of Neurotransmitters: The medication increases neurotransmitters such as norepinephrine, serotonin, and dopamine
One, it may well be that levels of serum B12 in the blood gradually decrease when treatment is stopped, but still remain within the low-normal range for several months or even a few years
The pivotal trial supporting its 2010 FDA approval enrolled 816 HIV-infected adults with clinically defined lipodystrophy, and Phase 3 data documented visceral fat reductions of roughly 15-18% over 26 weeks of treatment a result robust enough to clear FDA review for a defined medical indication
Toxicity of benzyl alcohol in adult and neonatal mice
The pattern in patient reviews: those reporting substantial weight loss (10+ pounds in 4 weeks) invariably mention concurrent dietary changes, increased exercise, or use of other medications (metformin, GLP-1 agonists)